Long-term immunovirologic control following antiretroviral therapy interruption in patients treated at the time of primary HIV-1 infection

Five out of 32 patients who received very early and prolonged antiretroviral therapy displayed an unusual, sustained immunovirological control after treatment discontinuation (mean duration: 77 months). These ‘post-treatment controllers’ did not have the genetic characteristics of spontaneous ‘elite’ controllers, although they shared very low and stable level of viral reservoir. Treatment may have dramatically decreased this reservoir and preserved potent HIV-specific immunologic responses, inducing a new balance between the virus and the host's immune system in these patients.

[1]  T. Perneger,et al.  Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions , 2004, AIDS.

[2]  Asier Sáez-Cirión,et al.  HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotype , 2007, Proceedings of the National Academy of Sciences.

[3]  C. Rouzioux,et al.  Early levels of HIV-1 DNA in peripheral blood mononuclear cells are predictive of disease progression independently of HIV-1 RNA levels and CD4+ T cell counts. , 2005, The Journal of infectious diseases.

[4]  C. Rouzioux,et al.  Spontaneous control of viral replication during primary HIV infection: when is "HIV controller" status established? , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[5]  S. Little,et al.  Treatment of acute HIV-1 infection: are we getting there? , 2008, Current opinion in HIV and AIDS.

[6]  C. Rouzioux,et al.  Impact of 5 years of maximally successful highly active antiretroviral therapy on CD4 cell count and HIV-1 DNA level , 2003, AIDS.

[7]  G. Ferrari,et al.  Acute HIV infection: the impact of anti‐retroviral treatment on cellular immune responses , 2007, Clinical and experimental immunology.

[8]  Persephone Borrow,et al.  The immune response during acute HIV-1 infection: clues for vaccine development , 2009, Nature Reviews Immunology.

[9]  Avettand‐Fènoël Véronique,et al.  LTR real‐time PCR for HIV‐1 DNA quantitation in blood cells for early diagnosis in infants born to seropositive mothers treated in HAART area (ANRS CO 01) , 2009 .

[10]  H. Agut,et al.  Combination of HIV-1-specific CD4 Th1 cell responses and IgG2 antibodies is the best predictor for persistence of long-term nonprogression. , 2005, The Journal of infectious diseases.

[11]  C. Rouzioux,et al.  HIV-DNA in rectal cells is well correlated with HIV-DNA in blood in different groups of patients, including long-term non-progressors , 2008, AIDS.

[12]  S. Rowland-Jones,et al.  Resisting Immune Exhaustion in HIV-1 Infection , 2008, PLoS medicine.

[13]  C. Rouzioux,et al.  HIV controllers: a homogeneous group of HIV-1-infected patients with spontaneous control of viral replication. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.